Stay updated on Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.

Latest updates to the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new page revision entry (v3.5.3) was added, replacing the prior revision (v3.5.2). This reflects a minor update to the page's revision history rather than substantive changes to study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2. This appears to be a metadata/backend update with no visible changes to study details or content.SummaryDifference0.0%

- Check44 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check86 days agoChange DetectedAdded a Resources entry for Genetic and Rare Diseases Information Center and introduced the hyphenated term 'Beta-thalassemia major'. Removed the government funding lapse notice and the older Revision 3.4.1 text; the page now shows Revision 3.4.2.SummaryDifference0.5%

- Check93 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety of Sotatercept in Beta-Thalassemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Sotatercept in Beta-Thalassemia Clinical Trial page.